Cingulate (NASDAQ:CING – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued to investors on Thursday,Benzinga reports.
Roth MKM analyst Boobalan Pachaiyappan maintained a Buy rating on Cingulate Inc (CING – Research Report) today and set a price target of $12.00. The company’s shares closed yesterday at $3.85.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AMN Healthcare Services (AMN – Research Report), Cingulate Inc (CING – Research Report ...